Universe Pharmaceuticals INC (UPC): Price and Financial Metrics

Universe Pharmaceuticals INC (UPC): $2.30

0.01 (+0.44%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add UPC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#38 of 349

in industry

UPC Price/Volume Stats

Current price $2.30 52-week high $3.12
Prev. close $2.29 52-week low $0.75
Day low $2.30 Volume 5,800
Day high $2.34 Avg. volume 87,172
50-day MA $2.29 Dividend yield N/A
200-day MA $1.71 Market Cap 8.34M

UPC Stock Price Chart Interactive Chart >


Universe Pharmaceuticals INC (UPC) Company Bio


Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Jiangxi, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.


UPC Latest News Stream


Event/Time News Detail
Loading, please wait...

UPC Latest Social Stream


Loading social stream, please wait...

View Full UPC Social Stream

Latest UPC News From Around the Web

Below are the latest news stories about UNIVERSE PHARMACEUTICALS INC that investors may wish to consider to help them evaluate UPC as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We're starting the week off right with a breakdown of the biggest pre-market stock movers worth knowing about on Monday morning!

William White on InvestorPlace | August 14, 2023

Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares

Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on August 1, 2023, notifying the Company that it is not in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement set forth in the Nasdaq L

Yahoo | August 4, 2023

Universe Pharmaceuticals INC Announces Share Consolidation

Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the “Share Consolidation”). As a result of the Share Conso

Yahoo | July 27, 2023

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Ji’an, Jiangxi, China, March 07, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on March 2, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Lis

Yahoo | March 7, 2023

Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19

Ji’an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that six varieties of the Company’s products were included in the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (the “Catalogue”), which was published by Beijing Health Commission on December 12, 2022. The included products are Banlangen Granules, Strong Loquat Extract, Pediatric Parac

Yahoo | December 21, 2022

Read More 'UPC' Stories Here

UPC Price Returns

1-mo -1.29%
3-mo 11.11%
6-mo 75.84%
1-year -19.97%
3-year -87.26%
5-year N/A
YTD 14.43%
2023 -76.90%
2022 -11.31%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!